drug delivery
Progenity Files for IPO, Seeks to Raise up to $100M
The company said that a large portion of the offering's proceeds would be used to end criminal and civil investigations over its past billing practices.
Startup Cadex Genomics Raises $1.5M
The firm's lead product is a blood-based assay, called Alibrex, which uses PCR technology to monitor stage IV solid tumor cancer therapy.
Genotyping Appears to Offer Warfarin Dosing Edge in New Clinical Trial
Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.
This article has been updated to clarify details regarding Traversa Therapeutics' bankruptcy proceedings.
Roughly one year after securing €5 million ($6.5 million) in venture capital funding, Spanish oligonucleotide drug developer nLife Therapeutics has set its sights on initiating non-human primate testing of its core intranasal delivery technology, which it hopes will spur licensin
Jan 10, 2013
Apr 12, 2012
Nov 17, 2011
Nov 10, 2011
Sep 8, 2011
May 12, 2011
Apr 14, 2011
Apr 14, 2011
Oct 14, 2010
Aug 5, 2010
Jun 10, 2010
May 20, 2010
Feb 11, 2010
Dec 17, 2009
Sep 24, 2009
People in the News: Sep 24, 2009
Premium
Jul 30, 2009
Jun 30, 2009